Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal versus standard surgical treatment in symptomatic uterine fibroids
2017-005120-16Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ulipristal in Fibromyoma (LM) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Change in UFS-QOL Symptom Severity Score from baseline, Quality of life and 1 more. Started Aug 2018; status: active.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on 2017-005120-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005120-16.